Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for GH Research PLC Ordinary Shares, nominal value $0.025 per share (GHRS).
- Disclosed ownership: 14%.
- Date of event: 31 Mar 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 14% ownership in GH Research PLC Ordinary Shares, nominal value $0.025 per share (GHRS) on 31 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 7.4% | 4,599,019 | 0 | 4,599,019 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 7.4% | 4,599,019 | 0 | 4,599,019 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 5.8% | 3,605,399 | 0 | 3,605,399 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 5.8% | 3,605,399 | 0 | 3,605,399 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 1% | 619,881 | 0 | 619,881 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 1% | 619,881 | 0 | 619,881 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 13% | 8,204,418 | 0 | 8,204,418 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 14% | 8,827,712 | 0 | 8,827,712 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 14% | 8,827,712 | 0 | 8,827,712 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 14% | 8,827,712 | 0 | 8,827,712 | /s/ Mark N. Lampert | Mark N. Lampert |